ID30205A - Asam-asam lemak esensial dalam pencegahan kejadian-kejadian kardiovaskular - Google Patents
Asam-asam lemak esensial dalam pencegahan kejadian-kejadian kardiovaskularInfo
- Publication number
- ID30205A ID30205A IDW00200101999A ID20011999A ID30205A ID 30205 A ID30205 A ID 30205A ID W00200101999 A IDW00200101999 A ID W00200101999A ID 20011999 A ID20011999 A ID 20011999A ID 30205 A ID30205 A ID 30205A
- Authority
- ID
- Indonesia
- Prior art keywords
- fatty acids
- essential fatty
- dha
- epa
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI000313A IT1308613B1 (it) | 1999-02-17 | 1999-02-17 | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
Publications (1)
Publication Number | Publication Date |
---|---|
ID30205A true ID30205A (id) | 2001-11-15 |
Family
ID=11381919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101999A ID30205A (id) | 1999-02-17 | 2000-02-07 | Asam-asam lemak esensial dalam pencegahan kejadian-kejadian kardiovaskular |
Country Status (26)
Country | Link |
---|---|
US (2) | US7462643B1 (de) |
EP (2) | EP1152755B1 (de) |
JP (2) | JP5441287B2 (de) |
KR (2) | KR20070098954A (de) |
CN (1) | CN1230159C (de) |
AT (1) | ATE216230T1 (de) |
AU (1) | AU775078B2 (de) |
BR (1) | BR0008153A (de) |
CA (1) | CA2362271C (de) |
CZ (1) | CZ301307B6 (de) |
DE (1) | DE60000133C5 (de) |
DK (1) | DK1152755T3 (de) |
EA (1) | EA004312B1 (de) |
ES (1) | ES2174814T3 (de) |
HK (1) | HK1044720B (de) |
HU (1) | HUP0200111A3 (de) |
ID (1) | ID30205A (de) |
IL (2) | IL144377A0 (de) |
IT (1) | IT1308613B1 (de) |
NO (1) | NO328797B1 (de) |
NZ (1) | NZ513093A (de) |
PL (1) | PL209078B1 (de) |
PT (1) | PT1152755E (de) |
SK (1) | SK286523B6 (de) |
WO (1) | WO2000048592A1 (de) |
ZA (1) | ZA200106029B (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
ITMI20010129A1 (it) | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
ITMI20012384A1 (it) | 2001-11-12 | 2003-05-12 | Quatex Nv | Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori |
ITMI20020269A1 (it) * | 2002-02-12 | 2003-08-12 | Victorix Assets Ltd | Uso di steri etilici di acidi poliinsaturi omega-3 in pazienti con insufficienza cardiaca |
GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
CA2485116C (en) | 2002-05-03 | 2013-02-05 | Pronova Biocare As | Use of epa and dha in secondary prevention |
ITMI20022511A1 (it) * | 2002-11-26 | 2004-05-27 | Victorix Assets Ltd | Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale. |
DE602005026582D1 (de) | 2005-03-11 | 2011-04-07 | Recon Oil Ind Private Ltd | Synergistisch hitzestabiles ölmedium mit eicosapentaensäure (epa) und docosahexaensäure (dha) |
WO2007007686A1 (ja) * | 2005-07-08 | 2007-01-18 | Mochida Pharmaceutical Co., Ltd. | 心血管イベント発症予防用組成物 |
JP5134916B2 (ja) * | 2005-07-08 | 2013-01-30 | 持田製薬株式会社 | 心血管イベント発症予防用組成物 |
JP2009523414A (ja) | 2005-12-21 | 2009-06-25 | ブルーディ、テクノロジー、ソシエダッド、リミターダ | 細胞の酸化的損傷に関連した病変を治療するためのdha、epaまたはdha由来のepaの使用 |
ES2277557B1 (es) * | 2005-12-21 | 2008-07-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo. |
BRPI0621313A2 (pt) | 2006-02-07 | 2011-12-06 | Mochilda Pharmaceutical Co Ltd | composição para previnir recorrência de acidente vascular cerebral |
US8853256B2 (en) | 2006-05-31 | 2014-10-07 | Mochida Pharmaceutical Co., Ltd. | Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
US20090264520A1 (en) * | 2008-04-21 | 2009-10-22 | Asha Lipid Sciences, Inc. | Lipid-containing compositions and methods of use thereof |
WO2010015335A1 (en) * | 2008-08-07 | 2010-02-11 | Spa Societa' Prodotti Antibiotici S.P.A. | Long-term treatment of symptomatic heart failure |
JPWO2010018856A1 (ja) * | 2008-08-13 | 2012-01-26 | 持田製薬株式会社 | カンナビノイド受容体関連疾患の予防/改善または治療剤 |
EP2475309A4 (de) * | 2009-09-08 | 2015-07-29 | Atrium Medical Corp | Herniapflaster |
WO2011080503A2 (en) | 2009-12-30 | 2011-07-07 | Equateq Limited | Simulated moving bed chromatographic separation process |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
GB201111591D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Further new process |
GB201111595D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Improved process |
GB201111589D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New modified process |
GB201111601D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New process |
GB201111594D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
KR101681907B1 (ko) * | 2012-02-27 | 2016-12-12 | 주식회사 케어사이드 | 혈액 순환 촉진 및 피부 질환 개선용 조성물 |
AU2013240427B2 (en) * | 2012-03-30 | 2017-08-03 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
EP3756658A1 (de) * | 2012-09-24 | 2020-12-30 | Aker Biomarine Antarctic As | Omega-3-zusammensetzungen |
GB201300354D0 (en) | 2013-01-09 | 2013-02-20 | Basf Pharma Callanish Ltd | Multi-step separation process |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US8802880B1 (en) | 2013-05-07 | 2014-08-12 | Group Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
EP3118186B1 (de) | 2013-12-11 | 2022-02-09 | Novasep Process | Chromatografische anlage zur herstellung von mehrfach ungesättigten fettsäuren |
BR112016015718B1 (pt) | 2014-01-07 | 2021-12-07 | Novasep Process Solutions | Processo de purificação de aminoácidos aromáticos |
PL237374B1 (pl) * | 2017-11-10 | 2021-04-06 | Lambdafin Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca mieszaninę estru etylowego kwasu eikozapentaenowego i estru etylowego kwasu dokozaheksaenowego oraz jej zastosowanie |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6034156A (ja) * | 1983-08-08 | 1985-02-21 | Hayashibara Biochem Lab Inc | エイコサペンタエン酸包接化合物及びこれを含有した飲食物 |
US4526902A (en) * | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
NO157302C (no) | 1985-12-19 | 1988-02-24 | Norsk Hydro As | Fremgangsmaate for fremstilling av et fiskeoljekonsentrat. |
US4920098A (en) | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
IT1205043B (it) | 1987-05-28 | 1989-03-10 | Innova Di Ridolfi Flora & C S | Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri |
GB2218984B (en) | 1988-05-27 | 1992-09-23 | Renafield Limited | Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses |
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
US5059622A (en) * | 1989-08-29 | 1991-10-22 | Biosyn, Inc. | Method for reducing blood pressure levels in hypertensive persons |
JP2893866B2 (ja) | 1990-05-25 | 1999-05-24 | 日本油脂株式会社 | 抗不整脈薬 |
US5324323A (en) | 1992-09-09 | 1994-06-28 | Telectronics Pacing Systems, Inc. | Multiple channel cardiosynchronous myoplasty apparatus |
US5208236A (en) | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
CA2151380A1 (en) | 1992-12-11 | 1994-06-23 | Peter Buhlmayer | Substituted benzazepinones |
CN1082909A (zh) * | 1993-01-03 | 1994-03-02 | 潘玉珍 | 精制二十二碳六烯酸乙酯复合溶栓、抗痴呆药剂 |
JPH07118229A (ja) | 1993-10-19 | 1995-05-09 | Fujisawa Pharmaceut Co Ltd | 尿素誘導体およびその製造法 |
US5760081A (en) * | 1994-05-10 | 1998-06-02 | The General Hospital Corporation | Omega 3 fatty acids in the prevention of ventricular fibrillation |
JPH0812581A (ja) | 1994-06-30 | 1996-01-16 | Fujirebio Inc | 虚血性心疾患治療剤 |
IT1274734B (it) | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
MY118354A (en) | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
IT1277953B1 (it) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
US6333447B1 (en) | 1996-03-29 | 2001-12-25 | The General Hospital Corporation | Transgenic model of heart failure |
US5861399A (en) | 1996-07-17 | 1999-01-19 | Heart Care Partners | Methods and compositions for the rapid and enduring relief of inadequate myocardial function |
AU741931B2 (en) | 1996-09-05 | 2001-12-13 | Collateral Therapeutics, Inc. | Gene therapy for congestive heart failure |
EP1004303B1 (de) | 1997-06-16 | 2004-10-13 | Nippon Suisan Kaisha, Ltd. | Zusammensetzung zum vermeiden von risikofaktoren beim sporttraining |
IT1308613B1 (it) | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
EP1130027A1 (de) | 2000-02-29 | 2001-09-05 | Aventis Pharma Deutschland GmbH | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
-
1999
- 1999-02-17 IT IT1999MI000313A patent/IT1308613B1/it active
-
2000
- 2000-02-07 IL IL14437700A patent/IL144377A0/xx active IP Right Grant
- 2000-02-07 PT PT00907510T patent/PT1152755E/pt unknown
- 2000-02-07 ES ES00907510T patent/ES2174814T3/es not_active Expired - Lifetime
- 2000-02-07 AU AU29075/00A patent/AU775078B2/en not_active Expired
- 2000-02-07 CZ CZ20012947A patent/CZ301307B6/cs not_active IP Right Cessation
- 2000-02-07 BR BR0008153-1A patent/BR0008153A/pt not_active Application Discontinuation
- 2000-02-07 HU HU0200111A patent/HUP0200111A3/hu unknown
- 2000-02-07 CA CA002362271A patent/CA2362271C/en not_active Expired - Lifetime
- 2000-02-07 ID IDW00200101999A patent/ID30205A/id unknown
- 2000-02-07 WO PCT/EP2000/000957 patent/WO2000048592A1/en not_active Application Discontinuation
- 2000-02-07 NZ NZ513093A patent/NZ513093A/xx not_active IP Right Cessation
- 2000-02-07 EA EA200100895A patent/EA004312B1/ru not_active IP Right Cessation
- 2000-02-07 DK DK00907510T patent/DK1152755T3/da active
- 2000-02-07 EP EP00907510A patent/EP1152755B1/de not_active Expired - Lifetime
- 2000-02-07 AT AT00907510T patent/ATE216230T1/de active
- 2000-02-07 CN CNB008050732A patent/CN1230159C/zh not_active Expired - Lifetime
- 2000-02-07 PL PL350851A patent/PL209078B1/pl unknown
- 2000-02-07 US US09/869,333 patent/US7462643B1/en not_active Expired - Fee Related
- 2000-02-07 KR KR1020077019755A patent/KR20070098954A/ko not_active Application Discontinuation
- 2000-02-07 JP JP2000599384A patent/JP5441287B2/ja not_active Expired - Lifetime
- 2000-02-07 DE DE60000133.4T patent/DE60000133C5/de not_active Expired - Lifetime
- 2000-02-07 KR KR1020017010387A patent/KR100823051B1/ko active IP Right Review Request
- 2000-02-07 SK SK1080-2001A patent/SK286523B6/sk not_active IP Right Cessation
- 2000-02-07 EP EP20020076100 patent/EP1247523A1/de not_active Withdrawn
-
2001
- 2001-07-17 IL IL144377A patent/IL144377A/en not_active IP Right Cessation
- 2001-07-23 ZA ZA200106029A patent/ZA200106029B/en unknown
- 2001-08-14 NO NO20013938A patent/NO328797B1/no not_active IP Right Cessation
-
2002
- 2002-08-29 HK HK02106382.1A patent/HK1044720B/zh not_active IP Right Cessation
-
2008
- 2008-08-15 US US12/192,627 patent/US20090018193A1/en not_active Abandoned
-
2010
- 2010-01-07 JP JP2010014742A patent/JP2010116414A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID30205A (id) | Asam-asam lemak esensial dalam pencegahan kejadian-kejadian kardiovaskular | |
US5198468A (en) | Essential fatty acid composition | |
CA1261274A (en) | Pharmaceutical and dietary compositions | |
EP2258447A3 (de) | Essentielle n-3 Fettsäure in der Therapie von Herzinsuffizienz und Herzversagen | |
PT1310249E (pt) | Utilizacao de acidos gordos poli-insaturados para prevencao primaria de eventos cardiovasculares graves | |
DE69935995D1 (de) | Polyungesättigen fettsäuren nährungsergänzung | |
FI970298A0 (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
BRPI0009373B8 (pt) | composições farmacêuticas orais contendo triglicerídeos de cadeia longa e tensoativos lipofílicos | |
DK0623019T3 (da) | Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr | |
NZ217703A (en) | 2-(2-fluoro-4-biphenylyl) propionic acid compositions | |
CA1287297C (en) | Iron - containing compositions and method for treatment of cancer | |
UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
CA2302641A1 (en) | Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation | |
CN1212867A (zh) | 防治心脑血管疾病的组合物 | |
HUP0000419A2 (hu) | Eikozapentaénsavat és/vagy sztearidonsavat tartalmazó gyógyászati készítmény |